Get the Stockscreener App
39.47
2.31%
-0.9336
Doximity Inc stock is traded at $39.47, with a volume of 954.84K.
It is down -2.31% in the last 24 hours and down -9.66% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$40.40
Open:
$40.31
24h Volume:
954.84K
Relative Volume:
0.39
Market Cap:
$7.44B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
39.47
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
-3.97%
1M Performance:
-9.66%
6M Performance:
-35.05%
1Y Performance:
-28.69%
1-Day Range:
$39.08
$40.49
1-Week Range:
$39.08
$41.65
52-Week Range:
$39.08
$85.21
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
39.49 | 7.61B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
220.74 | 36.85B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.52 | 12.03B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
83.38 | 7.29B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
38.48 | 7.23B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Are Telehealth Stocks Set to Tumble in 2026? - AOL.com
Doximity (DOCS) Fell as Guidance Fell Short of Expectations - Insider Monkey
Assessing Doximity (DOCS) Valuation After Cautious Earnings Guidance And Guarded Investor Sentiment - Yahoo Finance
Baillie Gifford & Co. Reduces Stock Position in Doximity, Inc. $DOCS - MarketBeat
OpenEvidence, Doximity Advance Dispute Over AI Platform Access - Bloomberg Law News
Insider Trends: What is the cash position of Doximity IncTrade Risk Report & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Overweight Doximity (DOCS) Position Weighs on Fund Performance - Insider Monkey
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance
Aubrey Capital Management Ltd Purchases Shares of 62,500 Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Hits New 12-Month LowHere's What Happened - MarketBeat
Doximity stock hits 52-week low at $39.92 amid challenging year - Investing.com Nigeria
Doximity stock hits 52-week low at $39.92 amid challenging year By Investing.com - Investing.com India
Wells Fargo & Company Upgrades Doximity (NYSE:DOCS) to Strong-Buy - MarketBeat
Doximity (NASDAQ:DOCS) Strengthens Professional Medical Networking - Kalkine Media
DOCS Analyst Rating Update: Wells Fargo Lowers Price Target | DO - GuruFocus
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
Assessing Doximity: Insights From 9 Financial Analysts - Benzinga
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino's Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - 24/7 Wall St.
Morgan Stanley views Doximity (DOCS) underperformance as attractive entry point amid strong engagement - MSN
Is It Time To Reconsider Doximity (DOCS) After Recent Share Price Weakness - Sahm
Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026 - 01net
Raymond James Sees 'Knee-Jerk' AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Finviz
Doximity (DOCS) Is Down 13.4% After Cutting 2026 Revenue Outlook Amid Regulatory PressuresWhat's Changed - Sahm
Raymond James Sees ‘Knee-Jerk’ AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Insider Monkey
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Bandwidth, Dynatrace, Paylocity, Doximity, and Agilysys Stocks Trade Down, What You Need To Know - The Globe and Mail
RSI Alert: Doximity (DOCS) Now Oversold - Nasdaq
Redlands Daily Facts - FinancialContent
Is Doximity (DOCS) Pricing Reflect Its Mixed Valuation Signals After Recent Share Price Slide - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - sharewise.com
Doximity (DOCS) declines more than market: Some information for investors - MSN
Winners Losers: Will Doximity Inc stock reach Wall Street targetsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Here's Why Doximity (DOCS) is a Strong Growth Stock - sharewise.com
Doximity (NASDAQ:DOCS) Sets New 1-Year LowWhat's Next? - MarketBeat
Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More - AOL.com
Ad Vital Founder Dr. Shitel Patel Featured in Doximity For Expertise on Practice Sustainability - Digital Journal
Penticton Herald: FinanceDoximity (DOCS) Shares Hit 52-Week Low: Analyzing the Digital Health Downturn - FinancialContent
Doximity stock hits 52-week low at 43.17 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.17 USD - Investing.com
Doximity (DOCS) Slid on Renewed Volatility - Yahoo Finance
As layoff loomed, exec turned to insider trading - Investment Executive
Volatility Watch: Will Doximity Inc stock benefit from upcoming earnings reportsOptions Play & Safe Entry Trade Reports - Bộ Nội Vụ
Doximity to settle securities litigation lawsuit for $31M - MSN
InvestingPro’s Fair Value model predicted Doximity’s 41% stock decline By Investing.com - Investing.com UK
Doximity reaches $31M settlement in securities litigation lawsuit - MSN
Understanding Momentum Shifts in (DOCS) - Stock Traders Daily
Morgan Stanley Views Doximity (DOCS) Underperformance as Attractive Entry Point Amid Strong Engagement - Insider Monkey
Doximity, Inc. (NYSE:DOCS) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):